Your browser doesn't support javascript.
loading
New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations.
Wicha, Sebastian G; Walz, Annabelle; Cherkaoui-Rbati, Mohammed H; Bundgaard, Nils; Kuritz, Karsten; Gumpp, Christin; Gobeau, Nathalie; Möhrle, Jörg; Rottmann, Matthias; Demarta-Gatsi, Claudia.
Affiliation
  • Wicha SG; Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
  • Walz A; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
  • Cherkaoui-Rbati MH; University of Basel, Basel, Switzerland.
  • Bundgaard N; Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.
  • Kuritz K; IntiQuan GmbH, Basel, Switzerland.
  • Gumpp C; IntiQuan GmbH, Basel, Switzerland.
  • Gobeau N; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
  • Möhrle J; University of Basel, Basel, Switzerland.
  • Rottmann M; Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.
  • Demarta-Gatsi C; Medicines for Malaria Venturegrid.452605.0, Geneva, Switzerland.
Antimicrob Agents Chemother ; 66(11): e0055622, 2022 11 15.
Article in En | MEDLINE | ID: mdl-36197116

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parasites / Malaria, Falciparum / Malaria / Antimalarials Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2022 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parasites / Malaria, Falciparum / Malaria / Antimalarials Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Antimicrob Agents Chemother Year: 2022 Type: Article Affiliation country: Germany